Jonathan Zalevsky Net Worth & Insider Trades

Jonathan Zalevsky - Chief R&D Officer, Nektar Therapeutics

As of August 17, 2023

What is Jonathan Zalevsky's Net Worth?

The current estimated net worth of Nektar Therapeutics's Chief R&D Officer, Jonathan Zalevsky, is estimated to be about $3.94M . Jonathan Zalevsky owns about 283,685 units of Nektar Therapeutics common stock. In the last 4 years at Nektar Therapeutics, Jonathan Zalevsky has sold an estimated value of $3.75M worth.

What is Jonathan Zalevsky's Past Insider Trading?

Jonathan Zalevsky's largest sale order was 31,111 units , worth over $569.33K on May 19, 2021. In total, Jonathan Zalevsky has made about 23 transactions over 4 years of their time at Nektar Therapeutics. Jonathan Zalevsky usually trades in August and November, with the busiest year in 2021 and 2020. The most recent transaction was a sale order of 9,703 units , worth over $7.57K on August 17, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jonathan Zalevsky

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jonathan Zalevsky's' Mailing Address?

  • Mailing address is 455 Mission Bay Boulevard South C/o Nektar Therapeutics San Francisco CA 94158 CA

What are Nektar Therapeutics's Past Insider Trades?

Nektar Therapeutics's most recent insider trade came on September 20, 2023 by Myriam Curet who sold 4,359 units worth $3.01K . In the last 20 years, insiders at Nektar Therapeutics have sold an estimated value of $295.36M and bought an estimated value of $84.98M worth of shares. Insider trading is most common in September, with the busiest year in 2017 and 2016. The most active traders at the company are Howard Robin, President & CEO,  Gil Labrucherie, SVP,  and Robert Chess, Director .

NEKTAR THERAPEUTICS Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...